{"id": "patient_01_q0", "query": "Which of the following is NOT part of the current treatment regimen for Mrs. Sample's DLBCL?", "options_scores": {"A": 7.386537075042725, "B": 6.469614028930664, "C": 5.029830455780029, "D": 6.8208441734313965, "E": 5.806952953338623}, "ranked_options": [{"letter": "C", "text": "Cyclophosphamide", "avg_nll": 5.029830455780029}, {"letter": "E", "text": "Doxorubicin", "avg_nll": 5.806952953338623}, {"letter": "B", "text": "Rituximab", "avg_nll": 6.469614028930664}, {"letter": "D", "text": "Vincristine", "avg_nll": 6.8208441734313965}, {"letter": "A", "text": "Polatuzumab vedotin", "avg_nll": 7.386537075042725}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q1", "query": "In the context of Mrs. Sample's other diagnoses, which of the following is NOT accurate based on the provided information?", "options_scores": {"A": 5.110442638397217, "B": 4.512285232543945, "C": 4.3876953125, "D": 5.414133071899414, "E": 6.113893508911133}, "ranked_options": [{"letter": "C", "text": "She has a mood disorder.", "avg_nll": 4.3876953125}, {"letter": "B", "text": "She was diagnosed with primary progressive type of multiple sclerosis.", "avg_nll": 4.512285232543945}, {"letter": "A", "text": "She has 2-vessel disease", "avg_nll": 5.110442638397217}, {"letter": "D", "text": "She has 3-vessel CHD.", "avg_nll": 5.414133071899414}, {"letter": "E", "text": "She has pre-existing ALS.", "avg_nll": 6.113893508911133}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q2", "query": "Which chronic, neuroinflammatory disease does Mrs. Sample suffer from? ", "options_scores": {"A": 3.7489757537841797, "B": 4.21012544631958, "C": Infinity, "D": 7.057859420776367, "E": 5.713827133178711}, "ranked_options": [{"letter": "A", "text": "Multiple sclerosis", "avg_nll": 3.7489757537841797}, {"letter": "B", "text": "Dementia", "avg_nll": 4.21012544631958}, {"letter": "E", "text": "Autoimmune encephalitis", "avg_nll": 5.713827133178711}, {"letter": "D", "text": "Brain abscess", "avg_nll": 7.057859420776367}, {"letter": "C", "text": "Parkinson", "avg_nll": null}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q3", "query": "Mrs. Sample takes Fingolimod. What is the dosis and when does the patient take it?", "options_scores": {"A": 5.536221981048584, "B": 5.9558939933776855, "C": 5.947725772857666, "D": 6.501334190368652, "E": 6.004395008087158}, "ranked_options": [{"letter": "A", "text": "0.5 mg, 1 capsule in the morning", "avg_nll": 5.536221981048584}, {"letter": "C", "text": "50 mg, 1 capsule in the morning", "avg_nll": 5.947725772857666}, {"letter": "B", "text": "0.5 mg, 1 capsule at bedtime", "avg_nll": 5.9558939933776855}, {"letter": "E", "text": "70 mg, 1 capsule in the morning", "avg_nll": 6.004395008087158}, {"letter": "D", "text": "35 mg, 1 capsule at bedtime", "avg_nll": 6.501334190368652}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q4", "query": "Which therapy regime does the oncology board recommend for Mrs. Sample?", "options_scores": {"A": 6.301467418670654, "B": 5.918317794799805, "C": 6.114562034606934, "D": 6.135360240936279, "E": 6.974082946777344}, "ranked_options": [{"letter": "B", "text": "7 cycles of R-Luna-CHT", "avg_nll": 5.918317794799805}, {"letter": "C", "text": "6 cycles of L-Pola-CRP", "avg_nll": 6.114562034606934}, {"letter": "D", "text": "6 cycles of R-Pola-CHP", "avg_nll": 6.135360240936279}, {"letter": "A", "text": "5 cycles of T-Pola-RHP", "avg_nll": 6.301467418670654}, {"letter": "E", "text": "8 cycles of M-Pola-CHZ", "avg_nll": 6.974082946777344}], "correct_answer_letter": "D", "error": null, "method": "local"}
{"id": "patient_01_q5", "query": "Mrs. Sample has bone metastasis, of which one was surgically addressed. Where was this metastasis located? ", "options_scores": {"A": 5.242115020751953, "B": 5.104615211486816, "C": 4.710865020751953, "D": 4.835865020751953, "E": 5.042115211486816}, "ranked_options": [{"letter": "C", "text": "Thoracic vertebra 10", "avg_nll": 4.710865020751953}, {"letter": "D", "text": "Thoracic vertebra 11", "avg_nll": 4.835865020751953}, {"letter": "E", "text": "Thoracic vertebra 12", "avg_nll": 5.042115211486816}, {"letter": "B", "text": "Thoracic vertebra 9", "avg_nll": 5.104615211486816}, {"letter": "A", "text": "Thoracic vertebra 8", "avg_nll": 5.242115020751953}], "correct_answer_letter": "C", "error": null, "method": "local"}
{"id": "patient_01_q6", "query": "On 01/09/2017, Mrs. Sample received a CT scan of her whole body. What kind of contrast agent was used?", "options_scores": {"A": 9.2398042678833, "B": 9.490731239318848, "C": 10.182282447814941, "D": 8.442575454711914, "E": 9.498730659484863}, "ranked_options": [{"letter": "D", "text": "Gadovist", "avg_nll": 8.442575454711914}, {"letter": "A", "text": "Omnipaque 320", "avg_nll": 9.2398042678833}, {"letter": "B", "text": "Imeron 400", "avg_nll": 9.490731239318848}, {"letter": "E", "text": "Xenetix 350", "avg_nll": 9.498730659484863}, {"letter": "C", "text": "Optiray 320", "avg_nll": 10.182282447814941}], "correct_answer_letter": "A", "error": null, "method": "local"}
{"id": "patient_01_q7", "query": "Mrs. Sample received multiple radiologic examinations. In which order did she receive them?", "options_scores": {"A": 8.460783004760742, "B": 7.083559989929199, "C": 8.202394485473633, "D": 8.911554336547852, "E": 8.352338790893555}, "ranked_options": [{"letter": "B", "text": "MR Brain > MR thoracic/lumbar spine > CT chest/abdomen/pelvis > CT Thoracic Spine > CT Thoracic Spine > CT chest/abdomen/pelvis > Abdominal ultrasound > MR Spine > Whole-body PET/CT > Liver MRI", "avg_nll": 7.083559989929199}, {"letter": "C", "text": "MR cervical spine > MR Head > CT Whole Body > CT Thoracic Spine", "avg_nll": 8.202394485473633}, {"letter": "E", "text": "CT Thoracic Spine > CT Whole Body > MR cervical spine > MR Head", "avg_nll": 8.352338790893555}, {"letter": "A", "text": "MR spine > MR Head > CT Thoracic Spine > CT Whole Body", "avg_nll": 8.460783004760742}, {"letter": "D", "text": "MR Brain > CT Thoracic Spine > MR cervical spine > CT Whole Body", "avg_nll": 8.911554336547852}], "correct_answer_letter": "B", "error": null, "method": "local"}
{"id": "patient_01_q8", "query": "Mrs. Sample’ medications changed between admission and discharge. Which of the following statements is correct?", "options_scores": {"A": 5.300786018371582, "B": 6.172687530517578, "C": 6.321009159088135, "D": 5.068378448486328, "E": 6.078323841094971}, "ranked_options": [{"letter": "D", "text": "The patient started taking prednisolone and is recommended to continue taking it for the rest of her life.", "avg_nll": 5.068378448486328}, {"letter": "A", "text": "Aspirin was discontinued.", "avg_nll": 5.300786018371582}, {"letter": "E", "text": "The patient started taking 2mg of Melatonin in the evening.", "avg_nll": 6.078323841094971}, {"letter": "B", "text": "The patient started taking Pregabalin 50 mg, 1-0-0-0", "avg_nll": 6.172687530517578}, {"letter": "C", "text": "The dose of Sertraline hydrochloride was increased from 50 mg to 100 mg.", "avg_nll": 6.321009159088135}], "correct_answer_letter": "E", "error": null, "method": "local"}
{"id": "patient_01_q9", "query": "Based on the medication changes from admission to discharge, which of the following best describes the Mrs Sample's evolving clinical situation?", "options_scores": {"A": 6.3492302894592285, "B": 6.003840446472168, "C": 6.735386848449707, "D": 5.82771110534668, "E": 6.1860761642456055}, "ranked_options": [{"letter": "D", "text": "The patient's mood disorder was deemed stabilized, leading to the discontinuation of Sertraline at discharge.", "avg_nll": 5.82771110534668}, {"letter": "B", "text": "The patient's pain management was escalated, as indicated by an increased frequency of Hydromorphone intake.", "avg_nll": 6.003840446472168}, {"letter": "E", "text": "The patient's immobility concerns were resolved, leading to the discontinuation of Enoxaparin sodium (Clexane®) at discharge.", "avg_nll": 6.1860761642456055}, {"letter": "A", "text": "The patient's cardiovascular risk was decreased, leading to a reduced number of cardiovascular medications at discharge.", "avg_nll": 6.3492302894592285}, {"letter": "C", "text": "The patient developed a new gastrointestinal issue, hence the introduction of Pantoprazole at discharge.", "avg_nll": 6.735386848449707}], "correct_answer_letter": "B", "error": null, "method": "local"}
